Cost-Benefit Decisions Will Reside With Docs/Patients, Not CMS – McClellan
This article was originally published in The Gray Sheet
Executive Summary
CMS will continue to refrain from incorporating cost-effectiveness analyses into coverage decisions, Administrator Mark McClellan affirmed May 18
You may also be interested in...
Health Plans Should Offer Choices For Technology Coverage – Wharton Prof
The U.S. Government should encourage the development of health insurance plans that provide consumers a choice of how new technology coverage decisions are made, according to a Wharton School researcher
Health Plans Should Offer Choices For Technology Coverage – Wharton Prof
The U.S. Government should encourage the development of health insurance plans that provide consumers a choice of how new technology coverage decisions are made, according to a Wharton School researcher
MedPAC Report Explores Ways For CMS To Use Cost-Effectiveness Analysis
CMS could select certain expensive medical devices, surgical and diagnostic procedures for government-sponsored cost-effectiveness research, according to MedPAC's June report to Congress